Showing results (151-160 of 263) with videos related to

Sort By:
Pageof 27
Journal of the National Cancer Institute|November 5, 1999
Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independenceD B Agus, C Cordon-Cardo, W Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcomaM Engelhardt, J Albanell, P Drullinsky, et al.
Oncogene|November 1, 1989
Activated ras genes in human seminoma: evidence for tumor heterogeneityM P Mulder, W Keijzer, A Verkerk, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1994
Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude miceC C Achkar, J M Bentel, J F Boylan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognostic significance of tissue polypeptide-specific antigen (TPS) in patients with advanced non-small cell lung cancerA van der Gaast, C H Schoenmakers, T C Kok, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
The urokinase-type plasminogen activator system in resected non-small-cell lung cancer. Rotterdam Oncology Thoracic Study GroupM Salden, T A Splinter, H A Peters, et al.
British Journal of Cancer|January 1, 1995
Mitoxantrone in metastatic apudomas: a phase II study of the EORTC Gastro-Intestinal Cancer Cooperative GroupJ P Neijt, A J Lacave, T A Splinter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
Alterations affecting the p53 control pathway in bilharzial-related bladder cancerI Osman, H I Scher, Z F Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan IndexM Imbriaco, S M Larson, H W Yeung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancerW K Kelly, I Osman, V E Reuter, et al.
Pageof 27